Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | MAP2K2 | P36507 | 5/20 | 0.38 |
| ▸ | MAP2K1 | Q02750 | 5/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | AURKA | O14965 | 1/20 | 0.36 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.36 |
| ▸ | KDR | P35968 | 1/20 | 0.36 |
| ▸ | MAP3K9 | P80192 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5872740 | 0.82 | MAP2K1 (0.46) | MAP2K2MAP2K1MEN1KMT2ATDP1 | |
| SCHEMBL5872805 | 0.82 | ALDH1A1 (0.51) | ALDH1A1TSHRMEN1KMT2AKDM4E | |
| SCHEMBL5872906 | 0.82 | MEN1 (0.47) | MAP2K2MAP2K1MEN1KMT2ATDP1 | |
| SCHEMBL5872758 | 0.81 | MAP2K1 (0.47) | MAP2K2MAP2K1MEN1KMT2ATDP1 | |
| SCHEMBL5872859 | 0.80 | MAP2K1 (0.43) | ALDH1A1ALOX15L3MBTL1MAP2K2MAP2K1 | |
| SCHEMBL5872799 | 0.80 | MAP2K1 (0.49) | L3MBTL1MAP2K2MAP2K1MEN1KMT2A | |
| SCHEMBL5872813 | 0.80 | MAP2K1 (0.43) | MAP2K2MAP2K1MEN1KMT2ATDP1 | |
| SCHEMBL5872918 | 0.79 | MAP2K1 (0.44) | MAP2K2MAP2K1MEN1KMT2ATDP1 | |
| SCHEMBL5873126 | 0.78 | MEN1 (0.42) | MAP2K2MAP2K1MEN1KMT2ATDP1 | |
| SCHEMBL5872782 | 0.78 | MAP2K1 (0.44) | MAP2K2MAP2K1MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7001905-B2 | Substituted diarylamines as MEK inhibitors | WARNER-LAMBERT COMPANY (US) | 2006-02-21 | — | — | US | disclosed |
| US-20030225076-A1 | 5-Amide substituted diarylamines as mex inhibitors | BIWERSI CATHLIN (US) | 2003-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225076-A1 | 5-Amide substituted diarylamines as mex inhibitors | NRAS, MAPK6, MAPK12 | ALDH1A1 1236/4885TSHR 1569/4885ALOX15 1849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.